Market Research Report Graft versus Host Disease Market Report

Graft versus Host Disease (GVHD) Market Insights,
Epidemiology and Market Forecast Report 2023
Market Research Hub (MRH) has recently announced the addition of a fresh report,
titled “Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and
Market Forecast-2023- EU5” to its report offerings. The report provides an overview
of the disease and global historical and forecasted epidemiological data for the
diagnosed incident cases of Hematopoietic stem cell transplantations (HSCTs) and
Graft Versus Host Disease (GVHD) based upon the sub-types of GVHD along with
the type of donor involved in the HSCTs, for the forecast period (2013-2023).
Request for Sample Report:
http://www.marketresearchhub.com/enquiry.php?type=S&repid=835106
GVHD is one of the severe complications associated with Hematopoietic stem cell
transplantations (HSCTs). DelveInsight forecasts predict an on-going increase in
HSCTs in the near future which shall lead to subsequent increase in the patient
population of GVHD. According to DelveInsights estimates, the total number of
diagnosed incident cases of Hematopoietic Stem Cell Transplants (HSCTs) shall
increase at a Compound Annual Growth Rate (CAGR) of 2.71% from 2013-2023
and reach up to 30,328 cases in the year 2023.
The incident rate of GVHD in unrelated donor (URD) is much higher in comparison
to the sibling donors (SD), irrespective of the sub-types i.e., acute GVHD (aGVHD)
or chronic GVHD (cGVHD). As per DelveInsight forecasts, the diagnosed incidence
cases of aGVHD in sibling donors and aGVHD in unrelated donors, shall increase
at a CAGR of 3.96% and 4.05%, respectively, from 2013-2023. In case of cGVHD,
the number of diagnosed incident population cGVHD in sibling donors and cGVHD
in unrelated donors is expected to accentuate at a CAGR of 4.05% and 4.04%,
respectively, by the end of the year 2023.